The Danish health care system and registries: potential and pitfalls for research
17 Jan 2023, 16:00 CET

In this webinar we have the honour of having Dr Morten Schmidt provide an overview of the Danish RWD landscape and the feasibility to utilize this data for outcomes research. He has several publications describing the different aspects of the RWD landscape in Denmark (see references below) and an extensive experience of using population-based data sources in research.

The aim with the webinar is to support Health Technology Evaluators and industry to understand what role data and research from Denmark may have to inform evaluations of new interventions / drugs.

Selected publications about the Danish RWD landscape:

  • Schmidt, Morten, Sigrun Alba Johannesdottir Schmidt, Kasper Adelborg, Jens Sundbøll, Kristina Laugesen, Vera Ehrenstein, and Henrik Toft Sørensen. The Danish Health Care System and Epidemiological Research: From Health Care Contacts to Database Records. Clin Epidemiol 11: 563–91.   
  • Schmidt, Morten, Lars Pedersen, and Henrik Toft Sørensen. The Danish Civil Registration System as a Tool in Epidemiology. Eur J Epidemiol. 2014 Aug;29(8):541-9
  • Schmidt, Morten, Sigrun Alba Johannesdottir Schmidt, Jakob Lynge Sandegaard, Vera Ehrenstein, Lars Pedersen, and Henrik Toft Sørensen. ‘The Danish National Patient Registry: A Review of Content, Data Quality, and Research Potential’. Clinical Epidemiology 7 (2015): 449–90.
  • Pottegård, Anton, Sigrun Alba Johannesdottir Schmidt, Helle Wallach-Kildemoes, Henrik Toft Sørensen, Jesper Hallas, and Morten Schmidt. ‘Data Resource Profile: The Danish National Prescription Registry’. International Journal of Epidemiology 46, no. 3 (01 2017): 798–798f.
  • Schmidt, Morten, Michael Maeng, Carl-Johan Jakobsen, Morten Madsen, Leif Thuesen, Per Hostrup Nielsen, Hans Erik Bøtker, and Henrik Toft Sørensen. ‘Existing Data Sources for Clinical Epidemiology: The Western Denmark Heart Registry’. Clinical Epidemiology 2 (9 August  2010): 137–44
  • Nielsen, Lene Hüche, Bjarne Linde Nørgaard, Hans Henrik Tilsted, Niels Peter Sand, Jesper Møller Jensen, Morten Bøttcher, Axel C. Diederichsen, et al. ‘The Western Denmark Cardiac Computed Tomography Registry: A Review and Validation Study’. Clinical Epidemiology 7 (2015): 53–64.
  • Schmidt, Morten, Lisbeth Vestergaard Andersen, Søren Friis, Knud Juel, and Gunnar Gislason. ‘Data Resource Profile: Danish Heart Statistics’. International Journal of Epidemiology 46, no. 5 (1 October 2017): 1368–69.
  • Schmidt, Morten, Jesper Hallas, Maja Laursen, and Søren Friis. ‘Data Resource Profile: Danish Online Drug Use Statistics (MEDSTAT)’. International Journal of Epidemiology 45, no. 5 (2016): 1401–2.
  • Sundbøll J, Adelborg K, Munch T, Frøslev T, Sørensen HT, Bøtker HE, Schmidt M. Positive predictive value of cardiovascular diagnoses in the Danish National Patient Registry: a validation study. BMJ Open. 2016 Nov 18;6(11):e012832.
  • Adelborg K, Sundbøll J, Munch T, Frøslev T, Sørensen HT, Bøtker HE, Schmidt M. Positive predictive value of cardiac examination, procedure and surgery codes in the Danish National Patient Registry: a population-based validation study. BMJ Open. 2016 Dec 9;6(12):e012817.
  • Schmidt M, Maeng M, Madsen M, Sørensen HT, Jensen LO, Jakobsen C-J. The Western Denmark Heart Registry: Its Influence on Cardiovascular Patient Care. J Am Coll Cardiol 2018;71(11):1259–72.

Speaker Biography: Morten Schmidt, MD, PhD, DMSc, Associate Professor

  • Department of Clinical Epidemiology, Aarhus University Hospital, Denmark
  • Department of Cardiology, Aarhus University Hospital, Denmark
  • Department of Clinical Medicine, Aarhus University, Denmark

Morten Schmidt is a leading figure within cardiovascular epidemiology. He combines clinical experience from cardiology training with 15 years of epidemiological training in three countries: Denmark, the UK, and the US. Dr Schmidt works with electronic health data. Among his areas of expertise are the cardiovascular risks of NSAIDs and the importance of comorbidity for cardiovascular disease. He has contributed significant methodological advances to clinical epidemiology. The largest validation studies of cardiovascular diagnoses and procedures worldwide are among his landmark papers along with numerous reviews on the research potential of Danish registries. In 2018, Dr Schmidt pioneered in introducing the target trial design in Denmark. His bibliometrics include 145 peer-reviewed papers in >60 different international journals, >13,000 citations and a H-index of 46. He is reviewer for more than 100 international journals, including NEJM, Nature, Lancet, and The BMJ. Dr Schmidt has received the most prestigious younger research award at Aarhus University (Jens Chr. Skou Award) and numerous awards from various medical societies. He is supported by the Novo Nordisk Foundation’s Research Leader Programme. He is advisory board member for studies initiated by the European Medicines Agency, and has been steering committee member of several Danish and international research societies. Currently he is vice-chair of the Cardiovascular Network at Aarhus University and leads a cardio-epidemiological research group of 12­–15 persons.